ADDEX THERAPEUTICS
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.
ADDEX THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2002-01-01
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.addextherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+41228841555
Email Addresses:
[email protected]
Total Funding:
203.88 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Global Site Tag Google Universal Analytics Cloudflare JS ReCAPTCHA V2 Infomaniak Network
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Indivior
Indivior investment in Post-IPO Equity - Addex Therapeutics
Armistice Master Fund LTV
Armistice Master Fund LTV investment in Post-IPO Equity - Addex Therapeutics
Indivior
Indivior investment in Post-IPO Equity - Addex Therapeutics
Innosuisse
Innosuisse investment in Grant - Addex Therapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Addex Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Addex Therapeutics
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Post-IPO Equity - Addex Therapeutics
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Addex Therapeutics
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Post-IPO Equity - Addex Therapeutics
Armistice Capital
Armistice Capital investment in Post-IPO Equity - Addex Therapeutics
Official Site Inspections
http://www.addextherapeutics.com Semrush global rank: 4.03 M Semrush visits lastest month: 2.66 K
- Host name: od-d1e2fa.infomaniak.ch
- IP address: 83.166.152.52
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Addex Therapeutics"
About us - Addex therapeutics
Overview. Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small …See details»
Overview - Addex therapeutics
Overview. Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.. Addex’s lead drug candidate, dipraglurant (mGlu5 …See details»
EN - Addex therapeutics
About us. Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for …See details»
Addex Therapeutics - LinkedIn
Addextherapeutics.com 19 Like Comment Share Addex Therapeutics 6,792 followers 3mo Report this post Today we reported our third quarter 2024 financial results and provided a corporate update. ...See details»
Addex Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +41228841555 Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and …See details»
Addex Therapeutics Ltd (ADXN) Company Profile & Facts - Yahoo …
See the company profile for Addex Therapeutics Ltd (ADXN) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Addex Therapeutics Ltd Company Profile - Overview - GlobalData
Website www.addextherapeutics.com Telephone 41 22 8841555. No of Employees 23. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange ADXN (SWF) Revenue (2022) …See details»
Addex Therapeutics (SWX:ADXN) Company Profile & Description
Ticker Symbol: ADXN: Exchange: SIX Swiss Exchange: Fiscal Year: January - December: Reporting Currency: CHF: ISIN Number: CH0029850754: SIC Code: 2834See details»
Addex Therapeutics - VentureRadar
"Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known …See details»
Addex Therapeutics - Craft
Oct 29, 2024 Addex Therapeutics has 5 employees across 2 locations and CHF1.61 m in annual revenue in FY 2023. See insights on Addex Therapeutics including office locations, …See details»
Media - Addex therapeutics
Tim Dyer. Chief Executive Officer. Tel: +41228841555 [email protected]. Mike Sinclair. Partner, Halsin Partners. Tel: +44(0)2073182955See details»
Addex Therapeutics Ltd – Swiss Biotech
Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.See details»
Addex Therapeutics - PitchBook
Addex Therapeutics General Information Description. Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and …See details»
Addex Therapeutics - Overview, News & Similar companies
Jan 31, 2024 Addex Therapeutics contact info: Phone number: +41 228841555 Website: www.addextherapeutics.com What does Addex Therapeutics do? Founded in 2002, Addex …See details»
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
4 days ago Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149. Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025-Addex …See details»
Addex Provides Year End Pipeline Development Update
[email protected]. Mike Sinclair. Partner, Halsin Partners +44 (0)20 7318 2955. [email protected]. James Carbonara. Hayden IR (646)-755-7412. [email protected]. …See details»
Addex therapeutics :: Addex and Indivior Extend Research Term of ...
Dec 8, 2022 Tim Dyer. Chief Executive Officer. Telephone: +41 22 884 15 55. [email protected]. Mike Sinclair. Partner, Halsin Partners +44 (0)7968 022075. …See details»
Pipeline - Addex therapeutics
Using an allosteric modulator platform and drug discovery and development expertise, we established a pipeline of clinical and preclinical programs. Click on CLINICAL AND PRE …See details»
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
4 days ago Tim Dyer Chief Executive Officer Telephone: +41 22 884 15 55 [email protected]: Mike Sinclair Partner, Halsin Partners +44 7968 022075 …See details»
Addex Shareholders Approve All Resolutions at Extraordinary
Dec 19, 2023 Tim Dyer Chief Executive OfficerTelephone: +41 22 884 15 55 [email protected] Mike Sinclair Partner, Halsin Partners +44 (0)20 7318 2955 …See details»